Articles

Poll

Podcasts

Slideshows

Videos

Gastroenterology

Gastroenterology condition center page is a comprehensive resource for clinical news and insights on digestive and GI conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for 

, IBS and IBD, Crohn's disease, and more.

This month in review spotlights HCPLive’s coverage of the ACG 2024 meeting, GI pipeline updates, and other news and research from October.

Gastroenterology Month in Review: October 2024

Anthony Kerbage, MD, describes disparities in 21 IBS clinical trials whose data was used to support the FDA approvals of 7 IBS-C and IBS-D drugs.

Disparities in IBS Clinical Trial Participation Suggest Healthcare Research Inequities

Mohammad Abuassi, MD, explains how classifying IBS based on triggers can aid the development of effective, personalized approaches to management.

Stress Triggers IBS Symptoms, Impacts Quality of Life More Than Diet, Study Finds

Jacqueline Khalil, DO, reviews findings from 2 studies about the association between hormone replacement therapy with IBS and gastric motility disorders.

Hormone Replacement Therapy Linked to Greater IBS, Gastric Motility Disorder Risk

A new study revealed patients with genetic variation of hCAZyme enzymes were more likely to reach success with low-carb diets to relieve IBS symptoms than those without.

Genetic Variation of Enzyme hCAZYme May Affect IBS Response to Low-Carb Diet

Brain-gut behavioral treatments, such as CBT and hypnotherapy, may alleviate abdominal pain in IBS, though no single therapy proves superior to others.

Brain-Gut Behavioral Treatments May Ease IBS Abdominal Pain, Needs More Research

Patients with greater HADS-D scores were less likely to achieve symptomatic response or remission with a 2-step dietary intervention for IBS.

Depression Symptoms May Impact Response to Dietary Intervention for IBS

Adherence to an adapted low FODMAP diet and its impact on IBS symptoms were not affected based on the presence of fibromyalgia.

Comorbid Fibromyalgia Does Not Impact Low FODMAP Diet Adherence, Outcomes for IBS

Linaclotide was safe and effective for patients with chronic constipation and IBS with constipation who switched after non-response to magnesium oxide.

Linaclotide Improves Symptoms, Quality of Life After Non-Response to Magnesium Oxide

In focus groups, patients indicated symptom bothersomeness and life interference should be included in clinical evaluation for disorders of gut-brain interaction.

Current IBS, Functional Dyspepsia Clinical Criteria Neglect Patient Experiences

On the HCPLive irritable bowel syndrome page, resources on the topics of medical news and expert insight into IBS can be found. Content includes articles, interviews, videos, podcasts, and breaking news on IBS, IBD, and more.

Irritable Bowel Syndrome